A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss

AGM Schilder, S Wolpert, S Saeed… - Nature …, 2024 - nature.com
Inhibition of Notch signalling with a gamma-secretase inhibitor (GSI) induces mammalian
hair cell regeneration and partial hearing restoration. In this proof-of-concept Phase I/IIa …

Apoptotic vesicles resist oxidative damage in noise-induced hearing loss through activation of FOXO3a-SOD2 pathway

X Huang, X Kou, T Zhan, G Wei, F He, X Mao… - Stem Cell Research & …, 2023 - Springer
Background Mesenchymal stem cell (MSC) transplantation is a promising therapeutic
approach for noise-induced hearing loss (NIHL). As the indispensable role of apoptosis in …

Preclinical prospects of investigational agents for hearing loss treatment

CG Le Prell - Expert Opinion on Investigational Drugs, 2023 - Taylor & Francis
Introduction: Hearing loss has a high prevalence, with aging, noise exposure, ototoxic drug
therapies, and genetic mutations being some of the leading causes of hearing loss. Health …

Ototoxicity: a high risk to auditory function that needs to be monitored in drug development

MP Pasdelou, L Byelyayeva, S Malmström… - Frontiers in Molecular …, 2024 - frontiersin.org
Hearing loss constitutes a major global health concern impacting approximately 1.5 billion
people worldwide. Its incidence is undergoing a substantial surge with some projecting that …

Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice

R Liu, W Shang, Y Liu, Y Xie, J Luan, T Zhang… - Cell Death …, 2024 - nature.com
Abstract The Fscn2 (Fascin2) gene encodes an actin cross-linking protein that is involved in
the formation of hair cell stereocilia and retina structure. Mutations in Fscn2 gene have been …

An evaluation of the drug permeability properties of human cadaveric in situ tympanic and round window membranes

JGS Veit, B Birru, Y Wang, R Singh, EM Arrigali… - Pharmaceuticals, 2022 - mdpi.com
It is estimated that hearing loss currently affects more than 1.5 billion people, or
approximately 20% of the global population; however, presently, there are no Food and …

Potentials and limitations of pharmaceutical and pharmacological applications of bile acids in hearing loss treatment

M Lewkowicz, M Jones, B Kovacevic… - Therapeutic …, 2022 - Taylor & Francis
Hearing loss is a worldwide epidemic, with approximately 1.5 billion people currently
struggling with hearing-related conditions. Currently, the most wildly used and effective …

[HTML][HTML] Transcriptomic Analysis Identifies Candidate Genes for Differential Expression during Xenopus laevis Inner Ear Development

SM Virk, C Trujillo-Provencio, EE Serrano - bioRxiv, 2024 - ncbi.nlm.nih.gov
Background The genes involved in inner ear development and maintenance of the adult
organ have yet to be fully characterized. Previous genetic analysis has emphasized the …

[HTML][HTML] Noise-induced hearing disorders: Clinical and investigational tools

CG Le Prell, OH Clavier, J Bao - The Journal of the Acoustical Society …, 2023 - pubs.aip.org
A series of articles discussing advanced diagnostics that can be used to assess noise injury
and associated noise-induced hearing disorders (NIHD) was developed under the umbrella …

[PDF][PDF] Farmácia Meixomil, Paços de Ferreira e Serviços Farmacêuticos do Centro Hospitalar do Médio Ave, EPE, Santo Tirso

CS Tavares - 2022 - repositorio-aberto.up.pt
RESUMO O presente relatório foi realizado no âmbito da unidade curricular Estágio, a qual
marca o fim do meu percurso no Mestrado Integrado em Ciências Farmacêuticas. O meu …